The antitumor drug Yondelis is a tristetrahydroisoquinoline alkaloid of natural (marine) origin. The drug has a complex mechanism of action aimed at transcription. It represses gene transcription and interacts with
Zanosar is used to treat pancreatic cancer. Its effect is due to slowing down the growth of malignant cells. The drug Zanosar has an anti-cancer effect thanks to the Alkyl
Zavedos is an antitumor drug from the group of anthracycline antibiotics. Idarubicin, being integrated into the DNA molecule, interacts with topoisomerase II and inhibits the synthesis of nucleic acids. Idarubicin
Zejula is a targeted drug from the PARP inhibitor group, prescribed for locally advanced or metastatic epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer (peritoneal). The drug is also
Zelborav is indicated for use in adult patients as a therapy for: unresectable or metastatic melanoma with BRAF V600 mutation; Erdheim-Chester disease Active ingredient: vemurafinib Prescription medicine.
Zepzelca is a medicine with the active substance lurbinectedin, indicated for the treatment of adult patients suffering from relapsed or refractory diffuse large B-cell lymphoma (DLBCL). This type of non-Hodgkin
Zikadia is indicated for locally advanced or metastatic ALK-positive non-small cell lung cancer. Active ingredient: ceritinib Prescription medicine
Treatment of metastatic prostate cancer – the use of Zoladex favorably influenced survival, similar to the effect of surgical castration; Mammary cancer. Treatment of advanced hormone-sensitive breast cancer in premenopausal
Zoledro is used to prevent complications associated with bone damage (pathological fractures, spinal cord compression, need for radiation therapy or bone surgery, hypercalcemia due to malignancy) in adult patients with
Zometa is a bone resorption inhibitor, belongs to the class of highly effective bisphosphonates that have a selective effect on bone tissue. It has direct antitumor properties, ensuring effectiveness in
Zykadia is an antineoplastic and immunomodulatory agent; protein kinase inhibitor. Indications: – locally advanced or metastatic non-small cell lung cancer (NSCLC), positive for anaplastic lymphoma kinase (ALK) in adult patients;
Zytiga. Treatment of metastatic castration-resistant prostate cancer (in combination with prednisolone). Active ingredient: abiraterone Prescription drug.